Exhale

The official blog of the Lung Institute.

COPD Symptoms Monitored with New App: The Future is Here

11 Aug 2016
| Under Product Reviews, Resources | Posted by | 8 Comments
COPD Symptoms Monitored with New App: The Future is Here

The next big thing to keep COPD symptoms monitored may have just arrived.

Monitoring one’s symptoms can be a difficult endeavor for those living with lung diseases such as chronic obstructive pulmonary disease (COPD), pulmonary fibrosis or emphysema. When quality of life seems to be slipping more every day, while daily chores become more challenging and as something as simple as preparing a meal can lead to complete exhaustion, finding time to check one’s vitals can often be neglected. Fortunately, however, help is here to keep COPD symptoms monitored in the form of an app on your phone, and its name is the COPD Navigator.

With your health in mind, the Lung Institute is here to break down the new COPD Navigator app, what it could mean for your life and discuss how you’re keeping your COPD symptoms monitored with this new app could help you.

Overview of the COPD Navigator to Keep COPD Symptoms Monitored

As it stands today, COPD affects roughly 24 million Americans, costing the U.S. about $50 billion annually, much of which results from exacerbations or flare-ups. Created and distributed by LifeMap Solutions, the smartphone application COPD Navigator was developed and released in partnership with pulmonologists from the Icahn School of Medicine at Mt. Sinai. Before seven months had passed, the app had enrolled 8,400 users.

Key Features of the COPD Navigator to Keep COPD Symptoms Monitored

Offering the ability to track symptoms and medications, share data with their caregivers, and learn about their disease through educational material within the app, COPD Navigator is simply one-of-a-kind. Integrating environmental data such as air quality information and allergen levels, the app can also help users understand how these conditions can affect their symptom expression.

In a feature that is critical for the checking of daily vitals, the app allows patients to input their symptoms and peak flow measurements, converting them into a raw symptom score. This score is then compared to the general scores of similar patients. If the user’s score exceeds the norm, an alert is generated and stored within the system for further review. Using this type of consistent and accurate reporting, it’s possible to have a full account of your respiratory health ready to present to your doctor, ultimately allowing more personalized care and guidance.

COPD Symptoms Monitored with New App: The Future is Here

Controlling More than Symptoms

Although the COPD Navigator is an excellent tool for keeping COPD symptoms monitored, if you’re looking to directly address disease progression, it may be time to consider cellular therapy. Rather than only addressing the symptoms of lung disease, cellular therapy may directly affect disease progression, may improve quality of life and pulmonary function within patients. For those who suffer from lung disease, a change in quality of life could mean the difference between struggling to walk to the mailbox and riding a bike.

If you or a loved one suffers from a chronic disease like COPD, pulmonary fibrosis, emphysema or other symptoms of lung disease, the Lung Institute may be able to help with a variety of adult cellular therapy options. Contact us today at (800) 729-3065 to see if you qualify for cellular therapy, and find out what cellular therapy could mean for you.

Interested in our review of COPD Symptoms Monitored with New App: The Future is HereShare your thoughts and comments below.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.